Frequency of autoimmune diseases in myasthenia gravis: A systematic review

International Journal of Neuroscience

Volumn 121, Issue 3, 2011, Pages 121-129

  Mao, Zhi Feng ^a   Yang, Long Xiu ^a   Mo, Xue An ^a   Qin, Chao ^a   Lai, Yong Rong ^a   He, Ning Yu ^a   Li, Tong ^a   Hackett, Maree L ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Autoimmune diseases; frequency; myasthenia; systematic review

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ALOPECIA; ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BEHCET DISEASE; CROHN DISEASE; EMBASE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PEMPHIGOID; PEMPHIGUS VULGARIS; PERNICIOUS ANEMIA; POLYMYOSITIS; PSORIASIS; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; VITILIGO;

AUTOIMMUNE DISEASES; BIAS (EPIDEMIOLOGY); COMORBIDITY; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; MALE; MYASTHENIA GRAVIS; ODDS RATIO; RESEARCH DESIGN; SEX FACTORS; THYROIDITIS, AUTOIMMUNE;

EID: 79952124955     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.539307     Document Type: Review

References (47)

1. Al-Moallem, M. A., Alkali, N. H., Hakami, M. A., & Zaidan, R. M. (2008). Myasthenia gravis: Presentation and outcome in 104 patients managed in a single institution. Annals of Saudi Medicine, 28, 341-345.
2. Bache, I., Nielsen, N. M., Rostgaard, K., Tommerup, N., & Frisch, M. (2007). Autoimmune diseases in a Danish cohort of 4,866 carriers of constitutional structural chromosomal rearrangements. Arthritis and Rheumatism, 56, 2402-2409. (Pubitemid 47173588)
3. Beekman, R., Kuks, J. B., & Oosterhuis, H. J. (1997). Myasthenia gravis: Diagnosis and follow-up of 100 consecutive patients. Journal of Neurology, 244, 112-118. (Pubitemid 27057957)
4. Chmura Kraemer, H., Periyakoil, V. S., & Noda, A. (2002). Kappa coefficients in medical research. Statistics in Medicine, 21, 2109-2129. (Pubitemid 34752626)
5. Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., et al. (1995). Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurologica Scandinavica, 91, 192-195.
6. Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., et al. (1993). Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology, 43, 1779-1783.
7. Citterio, A., Beghi, E., Millul, A., Evoli, A., Mantegazza, R., Antozzi, C., et al. (2009). Risk factors for tumor occurrence in patients with myasthenia gravis. Journal of Neurology, 256, 1221-1227.
8. Cooper, G. S., Bynum, M. L., & Somers, E. C. (2009). Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity, 33, 197-207.
9. Cooper, G. S., & Stroehla, B. C. (2003). The epidemiology of autoimmune diseases. Autoimmunity Review, 2, 119-125. (Pubitemid 37443848)
10. D'Alessandro, R., Granieri, E., Benassi, G., Tola, M. R., Casmiro, M., Mazzanti, B., et al. (1991). Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurologica Scandinavica, 83, 83-88.
11. Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G., & Mortensen, P. B. (2007). Epidemiology of autoimmune diseases in Denmark. Journal of Autoimmunity, 29, 1-9. (Pubitemid 47016917)
12. Goldman, M., Herode, A., Borenstein, S., & Zanen, A. (1984). Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis and Rheumatism, 27, 701-703. (Pubitemid 14089483)
13. Goulon, M., Estournet, B., & Tulliez, M. (1980). Myasthenia gravis and associated diseases. International Journal of Neurology, 14, 61-72.
14. Grimes, D. A., & Schulz, K. F. (2002). Bias and causal associations in observational research. Lancet, 359, 248-252. (Pubitemid 34113828)
15. Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008). Lifetime course of myasthenia gravis. Muscle & Nerve, 37, 141-149. (Pubitemid 351214160)
16. Guidetti, D., Sabadini, R., Bondavalli, M., Cavalletti, S., Lodesani, M., Mantegazza, R., et al. (1998). Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. European Journal of Epidemiology, 14, 381-387. (Pubitemid 28288462)
17. Hackett, M. L., Yapa, C., Parag, V., & Anderson, C. S. (2005). Frequency of depression after stroke: A systematic review of observational studies. Stroke, 36, 1330-1340.
18. Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. (1997). Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology, 84, 223-243. (Pubitemid 27398022)
19. Kanazawa, M., Shimohata, T., Tanaka, K., & Nishizawa, M. (2007). Clinical features of patients with myasthenia gravis associated with autoimmune diseases. European Journal of Neurology, 14, 1403-1404. (Pubitemid 350135302)
20. Lavrnic, D., Jarebinski, M., Rakocevic-Stojanovic, V., Stevic, Z., Lavrnic, S., Pavlovic, S., et al. (1999). Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurologica Scandinavica, 100, 168-174.
21. Lennon, V. A., Lindstrom, J. M., & Seybold, M. E. (1975). Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. Journal of Experimental Medicine, 141, 1365-1375.
22. Levin, N., Abramsky, O., Lossos, A., Karussis, D., Siegal, T., Argov, Z., et al. (2005). Extrathymic malignancies in patients withmyasthenia gravis. Journal of The Neurological Sciences, 237, 39-43. (Pubitemid 41384012)
23. Lew, W., Pai, M., Oxlade, O., Martin, D., & Menzies, D. (2008). Initial drug resistance and tuberculosis treatment outcomes: Systematic review and meta-analysis. Annals of Internal Medicine, 149, 123-134. (Pubitemid 352008599)
24. Marino, M., Ricciardi, R., Pinchera, A., Barbesino, G., Manetti, L., Chiovato, L., et al. (1997). Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism, 82, 438-443. (Pubitemid 27068608)
25. Matsui, N., Nakane, S., Nakagawa, Y., Kondo, K., Mitsui, T., Matsumoto, T., et al. (2009). Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. Journal of Neurology, Neurosurgery and Psychiatry, 80, 1168-1171.
26. Mellemkjaer, L., Pfeiffer, R. M., Engels, E. A., Gridley, G., Wheeler, W., Hemminki, K., et al. (2008). Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis and Rheumatism, 58, 657-666. (Pubitemid 351364863)
27. Oopik, M., Kaasik, A. E., & Jakobsen, J. (2003). A population-based epidemiological study on myasthenia gravis in Estonia. Journal of Neurology Neurosurgery and Psychiatry, 74, 1638-1643. (Pubitemid 37542051)
28. Oosterhuis, H. J. (1981a). Myasthenia gravis. A survey. Clinical Neurology and Neurosurgery, 83, 105-135.
29. Oosterhuis, H. J. (1981b). Observations of the natural history of myasthenia gravis and the effect of thymectomy. Annals of the New York Academy of Sciences, 377, 678-690.
30. Oosterhuis, H. J. (1989). The natural course of myasthenia gravis: A long-termfollow-up study. Journal of Neurology, Neurosurgery and Psychiatry, 52, 1121-1127.
31. Oosterhuis, H. J., & de Haas, W. H. (1968). Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation. Acta Neurologica Scandinavica, 44, 219-227.
32. Patrick, J., & Lindstrom, J. (1973). Autoimmune response to acetylcholine receptor. Science, 180, 871-872.
33. Pendlebury, S. T., & Rothwell, P. M. (2009). Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurology, 8, 1006-1018.
34. Potagas, C., Dellatolas, G., Tavernarakis, A., Molari, H., Mourtzouhou, P., Koutra, H., et al. (2004). Myasthenia gravis: Changes observed in a 30-year retrospective clinical study of a hospital-based population. Journal of Neurology, 251, 116-117. (Pubitemid 38210503)
35. Poulas, K., Tsibri, E., Kokla, A., Papanastasiou, D., Tsouloufis, T., Marinou, M., et al. (2001). Epidemiology of seropositive myasthenia gravis in Greece. Journal of Neurology, Neurosurgery and Psychiatry, 71, 352-356. (Pubitemid 32772533)
36. Ramagopalan, S. V., Dyment, D. A., Valdar, W., Herrera, B. M., Criscuoli, M., Yee, I. M., et al. (2007). Autoimmune disease in families with multiple sclerosis: A population-based study. Lancet Neurology, 6, 604-610. (Pubitemid 46921044)
37. Rastenyte, D., Vaitkus, A., Neverauskas, R., & Pauza, V. (2002). Demographic and clinical characteristics of patients with myasthenia gravis. Medicina (Kaunas), 38, 611-616.
38. Robertson, N. P., Deans, J., & Compston, D. A. (1998). Myasthenia gravis: A population-based epidemiological study in Cambridgeshire, England. Journal of Neurology, Neurosurgery and Psychiatry, 65, 492-496. (Pubitemid 28438878)
39. Roxanis, I., Micklem, K., & Willcox, N. (2001). True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: Implications for immunopathogenesis. Journal of Neuroimmunology, 112, 163-173.
40. Simpson, J. A. (1960). Myasthenia gravis, a new hypothesis. Scottish Medical Journal, 5, 419-436.
41. Somers, E. C., Thomas, S. L., Smeeth, L., & Hall, A. J. (2009). Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? American Journal of Epidemiology, 169, 749-755.
42. Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000).Meta-analysis of observational studies in epidemiology: A proposal for reporting meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008-2012. (Pubitemid 30214957)
43. Suzuki, S., Shimoda, M., Kawamura, M., Sato, H., Nogawa, S., Tanaka, K., et al. (2005). Myasthenia gravis accompanied by alopecia areata: Clinical and immunogenetic aspects. European Journal of Neurology, 12, 566-570. (Pubitemid 40956816)
44. Tellez-Zenteno, J. F., Cardenas, G., Estanol, B., Garcia-Ramos, G., & Weder-Cisneros,N. (2004). Associated conditions in myasthenia gravis: Response to thymectomy. European Journal of Neurology, 11, 767-773. (Pubitemid 39556757)
45. Toth, C., McDonald, D., Oger, J., & Brownell, K. (2006). Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurologica Scandinavica, 114, 124-132. (Pubitemid 44034261)
46. Tsinzerling, N., Lefvert, A. K., Matell, G., & Pirskanen-Matell, R. (2007). Myasthenia gravis: A long-term follow-up study of Swedish patients with specific reference to thymic histology. Journal of Neurology, Neurosurgery and Psychiatry, 78, 1109-1112.
47. Yu, Y. L., Hawkins, B. R., Ip, M. S., Wong, V., & Woo, E. (1992). Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurologica Scandinavica, 86, 113-119.